細菌凝結劑市場規模、佔有率、成長分析，按類型、來源、應用、最終用戶、地區 - 產業預測，2025-2032

2023年凝結細菌的全球市場規模為9183萬美元，從2024年的9927萬美元成長到2032年的1.851億美元，預計在預測期內（2025-2032年）複合年成長率為8.1。

由於健康意識的提高和對機能性食品需求的激增，凝結乳桿菌（一種類似於乳酸菌的有益細菌）的全球市場正在顯著成長。凝結芽孢桿菌以其治療用途而聞名，已被證明可以治療 IBS、發炎性腸道疾病(IBD) 和呼吸道感染疾病等疾病，以及許多類型的腹瀉，包括由輪狀病毒等感染疾病引起的腹瀉。此外，它還具有增強免疫系統的作用，並具有其他健康益處。然而，由於消費者對其有效性缺乏廣泛認知，其市場潛力在一定程度上受到限制。然而，新興經濟體不斷擴大的研發和對凝固劑產品日益成長的興趣為未來的成長機會帶來了希望。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 客戶和購買標準分析

凝結劑市場規模：依類型

• 市場概況
• 類型1
• 2型
• 類型3

凝結劑市場規模：依來源分類

• 市場概況
• 自然資源
• 植物
• 動物
• 臨床資訊來源
• 其他

凝結劑市場規模：依應用分類

• 市場概況
• 不含乳製品
• 乳製品
• 糧食
• 藥品
• 嬰兒營養
• 其他

凝結劑市場規模：依最終用戶分類

• 市場概況
• 飲食
• 化妝品產業
• 營養補充品製造商
• 藥品製造商
• 畜牧業和護理
• 其他

凝結劑市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Kerry Group plc（Ireland）
• Sabinsa Corporation（United States）
• Mitsubishi Chemical Foods Corporation（Japan）
• Sanzyme Biologics（India）
• Unique Biotech Limited（India）
• Syngen Biotech Co., Ltd.（China）
• Synbiotech（Taiwan）
• Ganeden（United States）
• Biosearch Life（Spain）
• ADM Protexin Limited（United Kingdom）
• Bactolac Pharmaceutical, Inc.（United States）
• Nutraceutix, Inc.（United States）
• Thorne Research Inc.（United States）
• Vitamer Labs Inc.（United States）
• Nutralliance Inc.（United States）
• **Microbax（India）
• Zytex Biotech Pvt. Ltd.（India）
• Bioflex（India）
• Fengchen Group Co., Ltd.（China）

結論和建議

Global Bacillus Coagulans Market size was valued at USD 91.83 million in 2023 and is poised to grow from USD 99.27 million in 2024 to USD 185.1 million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global market for Bacillus coagulans, a beneficial bacterium akin to lactobacillus, is witnessing significant growth driven by heightened health awareness and a surge in demand for functional foods. Known for its therapeutic applications, Bacillus coagulans is effective in treating various types of diarrhea, including those caused by infections like rotavirus, as well as conditions such as IBS, inflammatory bowel diseases (IBD), and respiratory infections. Furthermore, its role in bolstering the immune system presents additional health benefits. However, the market's potential is somewhat hindered by widespread consumer unawareness regarding its effectiveness. Nonetheless, the expansion of research and development and increased interest in Bacillus coagulans products in emerging economies presents promising opportunities for future growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bacillus Coagulans market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bacillus Coagulans Market Segmental Analysis

Global Bacillus Coagulans Market is segmented by Type, Sources, Application, End-Users and region. Based on Type, the market is segmented into Type1, Type2 and Type3. Based on Sources, the market is segmented into Natural Source, Plants, Animals, Clinical Sources and Others. Based on Application, the market is segmented into Non-Dairy, Dairy, Cereal, Drugs, Infant Nutrition and Others. Based on End-Users, the market is segmented into Food and Beverages, Cosmeceutical Industries, Nutraceutical Manufacturers, Pharmaceutical Manufacturers, Animal Husbandry and Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bacillus Coagulans Market

The global Bacillus Coagulans market is primarily driven by its significant benefits in addressing acne and various skin conditions, leading to an increased demand within the cosmetics industry. Cosmetic manufacturers are formulating innovative products infused with Bacillus Coagulans, highlighting its anti-aging properties across a wide range of items, including face masks, lotions, scrubs, gels, creams, and cleansers. Additionally, there is a growing trend towards the incorporation of Bacillus Coagulans as a cosmeceutical component in diverse cosmetic products, such as creams and powders. Its effectiveness in managing conditions like atopic dermatitis and eczema further elevates its use in moisturizers and anti-acne treatments, solidifying its role as a crucial ingredient in personal care formulations.

Restraints in the Global Bacillus Coagulans Market

The global Bacillus coagulans market faces certain constraints primarily related to safety concerns and side effects associated with its use. While generally considered safe, indiscriminate dosing can lead to gastrointestinal issues such as gas and bloating. The lack of familiarity with Bacillus coagulans in the human digestive system raises ongoing debates regarding its potential risks and adverse effects. Additionally, some identified strains are not suitable for probiotic applications, and the existing research on these probiotics remains limited. Furthermore, there is apprehension that Bacillus coagulans spores could potentially escape the digestive tract and affect other organs, posing risks for immunocompromised individuals or those with catheters, as this could lead to bacterial infections.

Market Trends of the Global Bacillus Coagulans Market

The Global Bacillus Coagulans market is witnessing significant growth, driven by a rising consumer shift towards health-conscious dietary choices, particularly in dairy-free and vegan segments. This trend is largely fueled by increasing lactose intolerance, milk protein allergies, and a burgeoning vegan population, leading to a heightened demand for non-dairy probiotics. Bacillus coagulans has emerged as a preferred ingredient due to its recognized safety by regulatory bodies like the FDA and EFSA, making its way into functional foods and supplements. Furthermore, its impressive stability during processing enhances its appeal, while affordability positions it as a viable alternative to potentially harmful chemicals in the food industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Customer & Buying Criteria Analysis

Global Bacillus Coagulans Market Size by Type & CAGR (2025-2032)

• Market Overview
• Type1
• Type2
• Type3

Global Bacillus Coagulans Market Size by Sources & CAGR (2025-2032)

• Market Overview
• Natural Source
• Plants
• Animals
• Clinical Sources
• Others

Global Bacillus Coagulans Market Size by Application & CAGR (2025-2032)

• Market Overview
• Non-Dairy
• Dairy
• Cereal
• Drugs
• Infant Nutrition
• Others

Global Bacillus Coagulans Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Food and Beverages
• Cosmeceutical Industries
• Nutraceutical Manufacturers
• Pharmaceutical Manufacturers
• Animal Husbandry and Care
• Others

Global Bacillus Coagulans Market Size & CAGR (2025-2032)

• North America (Type, Sources, Application, End-Users)
  • US
  • Canada
• Europe (Type, Sources, Application, End-Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Sources, Application, End-Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Sources, Application, End-Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Sources, Application, End-Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sabinsa Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Chemical Foods Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanzyme Biologics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Unique Biotech Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbiotech (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ganeden (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosearch Life (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM Protexin Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bactolac Pharmaceutical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutraceutix, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thorne Research Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitamer Labs Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutralliance Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• **Microbax (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zytex Biotech Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioflex (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fengchen Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations